Submission Details
| 510(k) Number | K163644 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | December 23, 2016 |
| Decision Date | May 19, 2017 |
| Days to Decision | 147 days |
| Submission Type | Traditional |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
K163644 is an FDA 510(k) clearance for the Nihon Kohden QP-160AK EEG Trend Program, a Amplitude-integrated Electroencephalograph (Class II — Special Controls, product code OMA), submitted by Nihon Kohden Corporation (Tokyo, JP). The FDA issued a Cleared decision on May 19, 2017, 147 days after receiving the submission on December 23, 2016. This device falls under the Neurology review panel. Regulated under 21 CFR 882.1400.
| 510(k) Number | K163644 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | December 23, 2016 |
| Decision Date | May 19, 2017 |
| Days to Decision | 147 days |
| Submission Type | Traditional |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
| Product Code | OMA — Amplitude-integrated Electroencephalograph |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 882.1400 |
| Definition | Measure And Record Electrical Activity Of The Brain By Acquisition Of Amplitude-integrated Electroencephalograph (electroencephalograph Signals That Have Been Filtered And Displayed In A Specific Manner). |